It’s good to be a bull.
Lack of mass media on the major indexes approaching new highs bodes well for the upside.
But even as Jim Cramer and Bill Gross make their cases for selling it’s always best to stay with the tape.
Our recent breakout in Celgene Corp. (CELG) has made its third accumulation day for the past two weeks while pegging a new high.
Lots of talk on the potential of Biotech in this market environment.
But we’re not so hot on how the borader sector is performing and will become concerned if the recent low-volume advance crumbles with heavy selling:
